To foster the exchange of best practices, discuss current research efforts and collaborations, and address challenges and opportunities to advance the field, you are invited to join a Special Interest Group (SIG) meeting on the Prevention of Substance Use during the Perinatal Period.
Opioids, marijuana, and other substance use during pregnancy are rapidly growing public health concerns with significant consequences to maternal and infant outcomes. The Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) have identified the prenatal period as an ideal opportunity for substance use prevention. Building off of the success of our 2020 inaugural meeting, this SIG meeting will provide an opportunity for prevention scientists to network, discuss current research efforts and collaborations, including mentorship, and address challenges and opportunities to advance the field.
This free virtual event will be held on Tuesday, August 17, 2021, 2:00 – 3:00 pm EDT (Washington, DC time), within the SPR Conference.
Conveners: Golfo Tzilos Wernette, Family Medicine, University of Michigan-Ann Arbor; José Luis Vázquez-Martínez, Inter-American Drug Abuse Control Commission (CICAD); and Steven Ondersma, Merrill-Palmer Skillman Institute, Wayne State University.
Those interested in presenting any innovative research or interventions regarding substance use during pregnancy and the perinatal period must submit a 250-word abstract by email to Golfo K. Tzilos Wernette, Ph.D. ( gtzilos [at] med [dot] umich [dot] edu ), Assistant Professor of Family Medicine and Psychiatry at the University of Michigan Medical School, no later than Tuesday, August 10. Time constraints will allow for only a small selection of submissions.
To attend the SIG meeting on August 17, please click here to register (ZOOM link)